Stockscreener 앱 받기
6.65
0.00%
0.00
시간 외 거래:
6.62
-0.03
-0.45%
Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스
VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - StockTitan
Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - MSN
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World
StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat
How to Take Advantage of moves in (VYGR) - Stock Traders Daily
HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
Equities Analysts Offer Predictions for VYGR Q3 Earnings - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Strong-Buy at Leerink Partnrs - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Upgraded at Leerink Partnrs - MarketBeat
Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified - Simply Wall St
Leerink Partners Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics - Benzinga
The Manufacturers Life Insurance Company Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Gene Therapy in CNS Disorder Market Rapid Growth at Deep Value Price :Voyager Therapeutics, Spark Therapeutics, Novartis – IndiaPolitics.com - IndiaPolitics.com
(VYGR) Technical Pivots with Risk Controls - Stock Traders Daily
Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain - Yahoo Finance
Intracranial Therapeutic Market Rewriting its Growth Cycle |Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, – IndiaPolitics.com - IndiaPolitics.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Short Interest Update - MarketBeat
Voyager Therapeutics Inc (VYGR)’s Market Momentum: Closing Strong at 6.76, Down -4.52 - The Dwinnex
Monitoring Voyager Therapeutics Inc (VYGR) after recent insider movements - Knox Daily
Analyzing the Impact of Earnings Reports on Voyager Therapeutics Inc Inc. (VYGR) Price Performance - The InvestChronicle
Nothing is Better Than Voyager Therapeutics Inc (VYGR) stock at the moment - SETE News
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Holdings Lessened by Dimensional Fund Advisors LP - MarketBeat
Are Voyager Therapeutics Inc (VYGR) shares a good deal now? - US Post News
Strong week for Voyager Therapeutics (NASDAQ:VYGR) shareholders doesn't alleviate pain of five-year loss - Simply Wall St
AQR Capital Management LLC Sells 291,259 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k By Investing.com - Investing.com Australia
Voyager Therapeutics Inc [VYGR] stock for 34,914 USD was sold by Fahey Sandell Jacquelyn - Knox Daily
Voyager Therapeutics Inc (VYGR) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
What is the investor’s view on Voyager Therapeutics Inc (VYGR)? - US Post News
(VYGR) Technical Data - Stock Traders Daily
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Insider Sells $34,914.18 in Stock - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k - Investing.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M - MSN
Armistice Capital LLC Raises Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics stock hits 52-week low at $5.95 By Investing.com - Investing.com Australia
Baird maintains Outperform rating on Voyager Therapeutics stock By Investing.com - Investing.com Canada
Closing Figures: Voyager Therapeutics Inc (VYGR)’s Negative Finish at 6.04, Down -0.98 - The Dwinnex
Voyager Therapeutics stock hits 52-week low at $5.95 - Investing.com
Great Point Partners LLC Invests $12.67 Million in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
What is Voyager Therapeutics Inc (VYGR) Stock Return on Shareholders’ Capital? - SETE News
(VYGR) Trading Report - Stock Traders Daily
Federated Hermes Inc. Acquires 2,638 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Petri Dish: A big week for the Wyss; bone adhesive gets NIH funding - The Business Journals
Voyageur Pharmaceuticals announces new line of Barium Contrast Formulations setting new standard - Proactive Investors Australia
FDA lifts partial clinical hold on Vigil Neuroscience’s Phase I VG-3927 trial - Clinical Trials Arena
Acadian Asset Management LLC Decreases Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyageur Pharmaceuticals Appoints Dr. Iryna Saranchova as Chief Science Officer, Enhancing the Company's Research and Innovation Leadership - InvestorNews Inc.
Voyageur Pharmaceuticals welcomes new chief science officer - Proactive Investors
2.02%
0.47%
자본화:
|
볼륨(24시간):